Proton Bio

About:

Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.

Website: https://www.portonbio.com/

Top Investors: Hillhouse Investment, Fosun Pharma, China Merchants Venture Capital, Huimei Capital, Huatai Zijin Investment

Description:

Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To address clients' therapeutic product demands at the pre-clinical, clinical, and commercial stages, the firm offers end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.